NVP-BAW2881
NVP-BAW2881 (BAW2881) is a potent, selective VEGFR tyrosine kinase inhibitor. It has demonstrated efficacy in suppressing both chronic and acute skin inflammation in preclinical models, making it a valuable research tool for studying angiogenesis and inflammatory diseases.
Product Specifications
CAS Number
861875-60-7
Product Name Alternative
C-Raf-1, BAW 2881, BAW2881, BAW-2881, c-Abl, B-Raf (V599E), BcrAbl, inhibit, NVP BAW2881, NVP-BAW 2881, NVPBAW2881, NVP-BAW2881, NVP-BAW-2881, Inhibitor, hVEGFR2, Vascular endothelial growth factor receptor, VEGFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
98.07% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:78 mg/mL (183.8 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.71 mM) ; Ethanol:16 mg/mL (37.7 mM)
Smiles
Nc1nccc (Oc2ccc3c (cccc3c2) C (=O) Nc2cccc (c2) C (F) (F) F) n1
Molecular Formula
C22H15F3N4O2
Molecular Weight
424.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog